Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.918
-0.022 (-0.76%)
Nov 21, 2024, 11:18 AM EST - Market open
Lisata Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
25
Market Cap
24.27M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Neuronetics | 72.71M |
Spectral AI | 27.26M |
NEXGEL | 6.73M |
NeurAxis | 2.46M |
CytoMed Therapeutics | 330.25K |
LSTA News
- 2 days ago - Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year' - GlobeNewsWire
- 8 days ago - Lisata Therapeutics, Inc. (LSTA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration - GlobeNewsWire
- 15 days ago - Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024 - GlobeNewsWire
- 21 days ago - Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events - GlobeNewsWire
- 24 days ago - Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis - GlobeNewsWire
- 2 months ago - Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor Events - GlobeNewsWire